| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Auxilium Pharmaceuticals, Inc. > News item |
Perseus-Soros reduces stake in Auxilium to less than 5%
By Lisa Kerner
Charlotte, N.C., Sept. 5 - Perseus-Soros BioPharmaceutical Fund, LP sold 200,000 shares of Auxilium Pharmaceuticals, Inc. stock between Aug. 30 and Sept. 5 priced from $19.75 to $20.22 each.
In addition, the investor sold 1,000,000 shares of the company's common stock on Aug. 29 at a price of $18.90 per share in a Rule 144 transaction.
The transactions were reported in a schedule 13D filing with the Securities and Exchange Commission.
Perseus-Soros owns 1,482,333 shares, or 3.7%, of the Malvern, Pa., biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.